Bibliography
- Lopez A, Tarrago T, Giralt E. Low molecular weight inhibitors of Prolyl Oligopeptidase: a review of compounds patented from 2003 to 2010. Expert Opin Ther Pat 2011;21(7):1023-44
- Williams RS, Cheng L, Mudge AW, Harwood AJ. A common mechanism of action for three mood-stabilizing drugs. Nature 2002;417:292-5
- Morain P, Lestage P, De Nanteuil G, S 17092: a prolyl endopeptidase inhibitor as a potential therapeutic drug for memory impairment. Preclinical and clinical studies. CNS Drug Rev 2002;8:31-52
- Mannisto PT, Venalainen J, Jalkanen A, Garcia-Horsman JA. Prolyl oligopeptidase: a potential target for the treatment of cognitive disorders. Drug News Perspect 2007;20:293-305
- Bellemere G, Morain P, Vaudry H, Jegou S. Effect of S 17092, a novel prolyl endopeptidase inhibitor, on substance P and alpha-melanocyte-stimulating hormone breakdown in the rat brain. J Neurochem 2003;84:919-29
- Garcia-Horsman JA. Prolyl oligopeptidase in brain function and dysfunction. CNS Neurol Disord Drug Targets 2011;10:296
- Harwood AJ. Prolyl oligopeptidase, inositol phosphate signalling and lithium sensitivity. CNS Neurol Disord Drug Targets 2011;10:333-9
- Lambeir AM. Interaction of Prolyl Oligopeptidase with alpha-Synuclein. CNS Neurol Disord Drug Targets 2011;10:349-54
- Morawski M, Schulz I, Zeitschel U, Role of prolyl oligopeptidase in intracellular transport and protein secretion. CNS Neurol Disord Drug Targets 2011;10:327-32
- Peltonen I, Myohanen TT, Mannisto PT. Association of prolyl oligopeptidase with conventional neurotransmitters in the brain. CNS Neurol Disord Drug Targets 2011;10:311-18
- Penttinen A, Tenorio-Laranga J, Siikanen A, Prolyl oligopeptidase: a rising star on the stage of neuroinflammation research. CNS Neurol Disord Drug Targets 2011;10:340-8
- Peltonen I, Jalkanen AJ, Sinerva V, Different effects of scopolamine and inhibition of prolyl oligopeptidase on mnemonic and motility functions of young and 8- to 9-month-old rats in the radial-arm maze. Basic Clin Pharmacol Toxicol 2010;106:280-7
- Rossner S, Schulz I, Zeitschel U, Brain prolyl endopeptidase expression in aging, APP transgenic mice and Alzheimer's disease. Neurochem Res 2005;30:695-702
- Laitinen KS, van Groen T, Tanila H, Brain prolyl oligopeptidase activity is associated with neuronal damage rather than beta-amyloid accumulation. Neuroreport 2001;12:3309-12
- Sleegers K, Lambert J-C, Bertram L, The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects. Trends Genet 2009;26:84-93
- Bekris LM, Mata IF, Zabetian CP. The genetics of Parkinson disease. J Geriatr Psychiatry Neurol 2010;23:228-42
- Saito M, Hashimoto M, Kawaguchi N, Synthesis and inhibitory activity of acyl-peptidyl-prolinalderivatives toward post-proline cleaving enzyme as nootropic agents. J Enzyme Inhib 1990;3:163-78
- Collins PJ, McMahon G, O'Brien P, O'Connor B. Purification, identification and characterisation of seprase from bovine serum. Int J Biochem Cell Biol 2004;36:2320-33
- Cunningham DF, O'Connor B. Identification and initial characterisation of a N-benzyloxycarbonyl-prolyl-prolinal (Z-Pro-prolinal)-insensitive 7-(N-benzyloxycarbonyl-glycyl-prolyl-amido)-4-methylcoumarin (Z-Gly-Pro-NH-Mec)-hydrolysing peptidase in bovine serum. Eur J Biochem 1997;244:900-3
- Lawandi J, Gerber-Lemaire S, Juillerat-Jeanneret L, Moitessier N. Inhibitors of prolyl oligopeptidases for the therapy of human diseases: defining diseases and inhibitors. J Med Chem 2010;53:3423-38
- Tenorio-Laranga J, Valero ML, Mannisto PT, Combination of snap freezing, differential pH two-dimensional reverse-phase high-performance liquid chromatography, and iTRAQ technology for the peptidomic analysis of the effect of prolyl oligopeptidase inhibition in the rat brain. Anal Biochem 2009;393:80-7
- Nolte WM, Tagore DM, Lane WS, Saghatelian A. Peptidomics of prolyl endopeptidase in the central nervous system. Biochemistry 2009;48:11971-81
- Warden CH, Fisler JS, Espinal G, Maternal influence of prolyl endopeptidase on fat mass of adult progeny. Int J Obes (Lond) 2009;33:1013-22
- Perroud B, Alvarado RJ, Espinal GM, In vivo multiplex quantitative analysis of 3 forms of alpha melanocyte stimulating hormone in pituitary of prolyl endopeptidase deficient mice. Mol Brain 2009;2:14
- Di Daniel E, Glover CP, Grot E, Prolyl oligopeptidase binds to GAP-43 and functions without its peptidase activity. Mol Cell Neurosci 2009;41:373-82